Stryker Ronda E has filed a notice to sell 550,000 shares of common stock, which is valued at approximately $186.8 million. This sale is significant as it reflects ongoing market activity and could influence investor sentiment in the surgical and medical instruments sector.

Background

Stryker Ronda E is associated with Stryker Corporation, a prominent player in the surgical and medical instruments and apparatus industry. The company is based in Portage, Michigan, and operates under the ticker symbol STRYKER on the NYSE. The recent filing was made on November 5, 2026, and follows a series of other filings, including a Form 4 on August 20, 2026.

What the Filing Says

The filing indicates that Ronda E Stryker plans to sell 550,000 shares of common stock. The approximate market value of this transaction is $186,807,500. The sale is scheduled to occur on November 6, 2026.

Impact

This transaction may affect various stakeholders, including current shareholders and potential investors in Stryker Corporation. As the surgical and medical instruments industry evolves, such sales can impact market dynamics and investor confidence.

What's Next

The filing does not say what happens next.

Details of the Transaction

Ronda E Stryker's planned sale of 550,000 shares comes from a significant acquisition made on May 1, 1974, when she acquired 10,000,000 shares from the estate of L. Lee Stryker. This transaction was categorized as an estate division, and the shares were not acquired through a gift transaction.

Brokerage Information

The shares are set to be sold through APEX Clearing, located at 350 N St. Paul St, Suite 300, Dallas, TX. This brokerage is responsible for facilitating the transaction on the NYSE, where Stryker Corporation's shares are traded.

Outstanding Shares

As of the filing date, there are a total of 383,573,000 shares of Stryker Corporation's common stock outstanding. This context can help investors understand the proportion of shares being sold relative to the total available in the market.

Signature and Filing Details

The notice was officially signed by Ronda E Stryker on November 5, 2026, the same day it was filed with the SEC. This adds a layer of transparency and accountability to the transaction.